Abstract
Liquid needle-free injectors employ high-velocity liquid jets to deliver drugs and vaccines. Several parameters are critical to the injection quality: nozzle diameter, volume of drug delivered, ampoule diameter, pressure that drives liquid volume, and impact gap (distance between piston and trigger). A physical model is presented to calculate the stagnation pressure of the injection jet. Two types of the injection systems were tested: a spring-powered system and a voice-coil powered system. The calculation results show that the variation of stagnation pressure with time matches the experimental measurement under the same system conditions. The maximum stagnation pressure determines whether the jet can erode and penetrate into the skin. The maximum stagnation pressure was calculated under three conditions: different volumes, different spring rates and different ampoule diameters, and the results were compared with the experimental measurements. The experiments validated the physical model.
Keywords: Liquid needle-free injection, modeling, stagnation pressure, jet, voice-coil, Resistant Force, Ring Seal
Drug Delivery Letters
Title: Stagnation Pressure in Liquid Needle-Free Injection: Modeling and Experimental Validation
Volume: 1 Issue: 2
Author(s): Kai Chen, Hua Zhou, Ji Li and Gary J. Cheng
Affiliation:
Keywords: Liquid needle-free injection, modeling, stagnation pressure, jet, voice-coil, Resistant Force, Ring Seal
Abstract: Liquid needle-free injectors employ high-velocity liquid jets to deliver drugs and vaccines. Several parameters are critical to the injection quality: nozzle diameter, volume of drug delivered, ampoule diameter, pressure that drives liquid volume, and impact gap (distance between piston and trigger). A physical model is presented to calculate the stagnation pressure of the injection jet. Two types of the injection systems were tested: a spring-powered system and a voice-coil powered system. The calculation results show that the variation of stagnation pressure with time matches the experimental measurement under the same system conditions. The maximum stagnation pressure determines whether the jet can erode and penetrate into the skin. The maximum stagnation pressure was calculated under three conditions: different volumes, different spring rates and different ampoule diameters, and the results were compared with the experimental measurements. The experiments validated the physical model.
Export Options
About this article
Cite this article as:
Chen Kai, Zhou Hua, Li Ji and J. Cheng Gary, Stagnation Pressure in Liquid Needle-Free Injection: Modeling and Experimental Validation, Drug Delivery Letters 2011; 1 (2) . https://dx.doi.org/10.2174/2210304x11101020097
DOI https://dx.doi.org/10.2174/2210304x11101020097 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aldosterone, Mineralocorticoid Receptor and the Metabolic Syndrome:Role of the Mineralocorticoid Receptor Antagonists
Current Vascular Pharmacology Probing Gallic Acid for Its Broad Spectrum Applications
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Recent Advances in Potential Treatment of Diabetes and Diabetic Vascular Complications by Bioactive Natural Products and New Synthetic Compounds)
Current Topics in Medicinal Chemistry Cullin-RING Ligases as Attractive Anti-cancer Targets
Current Pharmaceutical Design Interferons Mediate Antiviral Immunity with Special Reference to Influenza Virus
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Role of Toll-Like Receptor Pathways in the Mechanism of Type 1 Diabetes
Current Molecular Medicine Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation
Current Protein & Peptide Science Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Current Clinical Pharmacology Anti-Angiogenic Approaches to Malignant Gliomas
Current Cancer Drug Targets Toxicogenomics to Evaluate Endocrine Disrupting Effects of Environmental Chemicals Using the Zebrafish Model
Current Genomics Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs
Mini-Reviews in Medicinal Chemistry Targets to Tackle – The Pathophysiology of the Disease
Current Drug Targets Interactions of the Aryl Hydrocarbon Receptor with Inflammatory Mediators:Beyond CYP1A Regulation
Current Drug Metabolism Editorial (Thematic Issue: Synthetic Androgen and New Psycho-Active Compounds (Smart Drugs) Abuse and Dependance. Neuropathological and Toxicological Findings, with an Approach Designed For the Future)
Current Neuropharmacology GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy
CNS & Neurological Disorders - Drug Targets Anti-Allergic Potential of Herbs and Herbal Natural Products - Activities and Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Balance Between S6K-S6 and 4E-BP1 Depends on ERK Activity in Developing Neurons
Current Signal Transduction Therapy CRH-Like Peptides in Human Reproduction
Current Medicinal Chemistry Unique Challenges of Type 1 Diabetes in the Preschool Population
Current Diabetes Reviews A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease
Current Pharmaceutical Design